Hailan Wu

442 total citations
42 papers, 300 citations indexed

About

Hailan Wu is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Hailan Wu has authored 42 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 15 papers in Molecular Medicine and 13 papers in Infectious Diseases. Recurrent topics in Hailan Wu's work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (15 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Hailan Wu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (15 papers) and Antimicrobial Resistance in Staphylococcus (11 papers). Hailan Wu collaborates with scholars based in China, Australia and United States. Hailan Wu's co-authors include Beining Guo, Jing Zhang, Yuancheng Chen, Yaxin Fan, Xiaofen Liu, Jufang Wu, Xiaojie Wu, Guoying Cao, Jicheng Yu and Junzhen Wu and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Hailan Wu

39 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hailan Wu China 11 142 112 88 74 50 42 300
Elizabeth A. Lakota United States 9 143 1.0× 112 1.0× 144 1.6× 174 2.4× 57 1.1× 28 425
Paola Della Siega Italy 10 109 0.8× 82 0.7× 112 1.3× 90 1.2× 30 0.6× 19 278
Jinyao Sun China 14 193 1.4× 127 1.1× 160 1.8× 114 1.5× 86 1.7× 18 478
Zahra Ghafouri Iran 7 75 0.5× 161 1.4× 36 0.4× 61 0.8× 67 1.3× 16 314
Aniello Alfieri Italy 11 91 0.6× 125 1.1× 31 0.4× 55 0.7× 28 0.6× 32 275
Kim‐Hor Hee Singapore 11 138 1.0× 59 0.5× 90 1.0× 77 1.0× 83 1.7× 18 320
Jufang Wu China 14 241 1.7× 163 1.5× 155 1.8× 153 2.1× 51 1.0× 39 466
Kate E. Rogers Australia 10 168 1.2× 160 1.4× 35 0.4× 75 1.0× 143 2.9× 14 384
Lionell Mandell Canada 7 233 1.6× 92 0.8× 60 0.7× 114 1.5× 77 1.5× 8 406
Silvia Arrigucci Italy 8 162 1.1× 90 0.8× 80 0.9× 97 1.3× 75 1.5× 11 362

Countries citing papers authored by Hailan Wu

Since Specialization
Citations

This map shows the geographic impact of Hailan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailan Wu more than expected).

Fields of papers citing papers by Hailan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailan Wu. The network helps show where Hailan Wu may publish in the future.

Co-authorship network of co-authors of Hailan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hailan Wu. A scholar is included among the top collaborators of Hailan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailan Wu. Hailan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Xiaofen, Lei Yang, Meihua Wang, et al.. (2025). Aerosolized delivery resulting in high polymyxin B concentration levels in epithelial lining fluid ensures efficacy in ventilator-associated pneumonia. JAC-Antimicrobial Resistance. 7(2). dlaf023–dlaf023.
4.
Wu, Hailan, et al.. (2024). Association of Sleep Duration with Risk of All-Cause and Cause-Specific Mortality Among American Adults: A Population-Based Cohort Study. Nature and Science of Sleep. Volume 16. 949–962. 4 indexed citations
5.
Wu, Hailan, et al.. (2024). Qualitative and quantitative analysis of solid renal tumors by high-frame-rate contrast-enhanced ultrasound. Cancer Imaging. 24(1). 139–139. 1 indexed citations
6.
Wang, Peipei, Xin Li, Qiong Wei, et al.. (2023). A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects. International Journal of Antimicrobial Agents. 63(2). 107075–107075. 2 indexed citations
7.
Li, Yi, Jufang Wu, Jicheng Yu, et al.. (2023). Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring. European Journal of Pharmaceutics and Biopharmaceutics. 188. 153–160. 1 indexed citations
8.
Li, Yi, Kaoru Toyama, Hitoshi Ishizuka, et al.. (2023). Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study. Advances in Therapy. 40(4). 1628–1643. 4 indexed citations
9.
Wu, Junzhen, Xinyi Yang, Jufang Wu, et al.. (2023). Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis. Frontiers in Pharmacology. 14. 1135007–1135007. 5 indexed citations
10.
Chen, Yan, Beining Guo, Hailan Wu, et al.. (2023). A simple and rapid HPLC-MS/MS method for therapeutic drug monitoring of amikacin in dried matrix spots. Journal of Chromatography B. 1220. 123592–123592. 4 indexed citations
11.
Chen, Yuancheng, Jiali Hu, Xiaolan Huang, et al.. (2022). Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model. Molecules. 27(3). 1085–1085. 7 indexed citations
12.
13.
Yu, Zhenwei, Xiaofen Liu, Xiaoxing Du, et al.. (2022). Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae. Frontiers in Pharmacology. 13. 975066–975066. 17 indexed citations
14.
Wu, Hailan, Yuhang Wu, Shuang Li, et al.. (2022). Safety and clinical efficacy of linezolid in children: a systematic review and meta-analysis. World Journal of Pediatrics. 19(2). 129–138. 15 indexed citations
15.
Li, Xin, Yuancheng Chen, Yi Li, et al.. (2021). Pharmacokinetics and Pharmacodynamics of Nemonoxacin in a Neutropenic Murine Lung Infection Model Against Streptococcus Pneumoniae. Frontiers in Pharmacology. 12. 658558–658558. 5 indexed citations
16.
Li, Wanzhen, Hailan Wu, Yuancheng Chen, et al.. (2021). Pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose intravenous ceftobiprole in healthy Chinese participants. Annals of Translational Medicine. 9(11). 936–936. 3 indexed citations
17.
Wang, Bo, Geng Li, Jingwen Weng, et al.. (2020). Effect of Weekly Antibiotic Round on Antibiotic Use in the Neonatal Intensive Care Unit as Antibiotic Stewardship Strategy. Frontiers in Pediatrics. 8. 604244–604244. 11 indexed citations
18.
Li, Li, Hailan Wu, Yuancheng Chen, et al.. (2020). Population Pharmacokinetics Study of Contezolid (MRX-I), a Novel Oxazolidinone Antibacterial Agent, in Chinese Patients. Clinical Therapeutics. 42(5). 818–829. 19 indexed citations
19.
Wu, Hailan, et al.. (2017). Ilex latifolia Thunb protects mice from HFD-induced body weight gain. Scientific Reports. 7(1). 14660–14660. 13 indexed citations
20.
Li, Geng, et al.. (2012). Risk factors of retinopathy of prematurity. Zhonghua jizhen yixue zazhi. 21(8). 869–873. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth A. Lakota Breakdown of academic impact, for papers by Paola Della Siega Breakdown of academic impact, for papers by Jinyao Sun Breakdown of academic impact, for papers by Zahra Ghafouri Breakdown of academic impact, for papers by Aniello Alfieri Breakdown of academic impact, for papers by Kim‐Hor Hee Breakdown of academic impact, for papers by Jufang Wu Breakdown of academic impact, for papers by Kate E. Rogers Breakdown of academic impact, for papers by Lionell Mandell Breakdown of academic impact, for papers by Silvia Arrigucci
Rankless by CCL
2026